Lung cancer is the deadliest disease and still is the most common cause of death. This is the obvious fact that smoking is the major cause of lung cancer but 10%-20% of…
Category: Lung Cancer News
FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with NSCLC (non-small cell lung cancer). This approval has been based on the…
Researchers develop AI Tool, Sybil, to Predict Lung Cancer Risk
A new study has been conducted by investigators from the Mass General Cancer Center in collaboration with researchers at the Massachusetts Institute of Technology (MIT) to develop and test an Artificial Intelligence…
Sarunashi Fruit May Inhibit Lung Cancer Growth, Study Finds
The researchers from Okayama University in Japan have found evidence that ingesting juice from sarunashi fruit can help prevent and reduce lung cancer via a mouse model. Lung cancer is the second…
Lung Cancer Increased by 5% in Last Two Years: Central Govt India
The disease of lung cancer is a significant health concern all around the world. Its alarming rise is becoming serious issue among people of all ages. According to the govt figures, Lung…
U.S. FDA Approves Lung Cancer Drug, Adagrasib
The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated locally advanced or metastatic non-small cell lung cancer in adults. This accelerated…
Breathe Test to Detect Lung Cancer, Scientists Suggests
Lung cancer is one of the most common types of cancers all around the world and has the highest death rate. The reason behind high death rate is that it is often…
Study Shows Alarming Rise in Lung Cancer Cases among non-smokers, Youth and Women
A study has been conducted by team of doctors from Medanta Gurugram, India that suggests possible increase in non-smokers and women lung cancer cases. Dr. Arvind Kumar and his team studied 304…